Form 8-K PROGENICS PHARMACEUTICAL For: Apr 28
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Tech stocks pull Wall Street lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Progenics Pharma (PGNX) Misses Q1 EPS by 5c
May 5, 2016 9:38 AM EDTProgenics Pharma (NASDAQ: PGNX) reported Q1 EPS of ($0.18), $0.05 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $2.5 million versus the consensus estimate of $3.27 million.
For earnings history and earnings-related data on Progenics Pharma (PGNX) click here.
... More